Dr. Larry Lavery, Principal Investigator and Professor of Plastic Surgery at the University of Texas Southwestern Medical Center, will discuss the primary and secondary endpoints as well as additional key safety data from the trial.
http://eon.businesswire.com/news/eon/20130905006636/en/Grafix%C2%AE-Diabetic-Foot-Ulcer-Clinical-Trial-Accepted
http://eon.businesswire.com/news/eon/20130905006636/en/Grafix%C2%AE-Diabetic-Foot-Ulcer-Clinical-Trial-Accepted
No comments:
Post a Comment